On June 24, 2013, the U. S. Supreme Court reversed a First Circuit ruling which held that the consumer of a generic drug can bring a design defect claim against its manufacturer under state law, pointing out that generics makers cannot change a drug's design under federal law. Bowman and Brooke's Randy Christian spoke with Law360 about the decision.
Read the Law360 article.